Persistent neuropsychological deficit in euthymic bipolar patients: Executive function as a core deficit

Journal of Clinical Psychiatry

Volumn 68, Issue 7, 2007, Pages 1078-1086

  Mur, Maria ^a,d   Portella, Maria J ^a,c   Martínez Arán, Anabel ^b   Pifarré, Josep ^a   Vieta, Eduard ^b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; ATTENTION; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; EDUCATION; FEMALE; HAMILTON SCALE; HUMAN; INFORMATION PROCESSING; INHIBITION (PSYCHOLOGY); INTELLIGENCE QUOTIENT; MALE; MONOTHERAPY; MOOD; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REMISSION; SOCIAL PSYCHOLOGY; VELOCITY; VERBAL MEMORY; VISUAL MEMORY;

EID: 34548331145     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v68n0715     Document Type: Article

References (39)

1. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998;28:1027-1038
2. van Gorp WG, Altshuler L, Theberge DC, et al. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence: a preliminary study. Arch Gen Psychiatry 1998;55:41-46
3. Ferrier IN, Stanton BR, Kelly TP, et al. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999;175:246-251
4. Clark L, Iversen S, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002;180:313-319
5. Cavanagh JTO, Van Beck M, Muir W, et al. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002;180:320-326
6. Raymont V, Bettany D, Frangou S. The Maudsley Bipolar Disorder Project: clinical characteristics of bipolar disorder I in a Catchment area treatment sample. Eur Psychiatry 2003;18:13-17
7. Donaldson S, Goldstein LH, Landau S, et al. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003;64:86-93
8. Martínez-Arán A, Vieta E, Colom F, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262-270
9. Thompson JM, Gallagher P, Hughes JH, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40
10. Frangou S, Donaldson S, Adjulis M, et al. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005;58:859-864
11. Martinez-Aran A, Vieta E, Colom F, et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000;69:2-18
12. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002;72:209-226
13. Savitz J, Solms M, Ramesar RS. Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 2005;7:216-235
14. Krabbendam L, Arts B, van Os J, et al. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005;80:137-149
15. Martínez-Arán A, Penadés R, Vieta E, et al. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2002;71:39-46
16. Bowden CL. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology 1998;19:194-199
17. Bauer MS, Mitchner L. What is a "mood stabilizer"? an evidence-based response. Am J Psychiatry 2004;161:3-18
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
19. Pachet AK, Wisniewski AM. The effects of lithium on cognition: an updated review. Psychopharmacology (Berl) 2003;170:225-234
20. MacQueen GM, Marriott M, Begin H, et al. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003;5:349-355
21. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 1997;95:361-363
22. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 2006;8:103-116
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
24. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
25. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version, User's Guide. Barcelona, Spain: Masson; 1999
26. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003;64:680-690
27. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York, NY: Oxford University Press; 2004
28. Wechsler D. Wechsler Adult Intelligence Scale-III. Technical Manual (Spanish Version). Madrid, Spain: TEA Ediciones; 2001
29. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in bipolar disorder. Curr Med Res Opin 2004;20:139-154
30. Baird A, Dewar BK, Critchlev H, et al. Cognitive functioning after medial frontal lobe damage including the anterior cingulate cortex: a preliminary investigation. Brain Cogn 2006;60:166-175
31. Frangou S, Dakhil N, Landau S, et al. Fronto-temporal function may distinguish bipolar disorder from schizophrenia. Bipolar Disord 2006;8:47-55
32. Kronhaus DM, Lawrence NS, Williams AM, et al. Stroop performance in bipolar disorder: further evidence for abnormalities in the ventral prefrontal cortex. Bipolar Disord 2006;8:28-39
33. Maj M, Pirozzi R, Magliano L, et al. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998;155:30-35
34. Glahn DC, Bearden CE, Niendam TA, et al. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004;6:171-182
35. Manji HK, Duman RS. Impairments on neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001;35:5-49
36. Martinez-Aran A, Vieta E, Colom F, et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 2005;74:295-302
37. Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007;9:103-113
38. Zarate CA Jr, Tohen M, Land M, et al. Functional impairment and cognition in bipolar disorder. Psychiatr Q 2000;71:309-329
39. Monks PJ, Thompson JM, Bullmore ET, et al. A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disord 2004;6:550-564